PTC Therapeutics, Inc. (PTCT)
63.46
-0.67
(-1.04%)
USD |
NASDAQ |
Oct 02, 16:00
63.49
+0.03
(+0.05%)
After-Hours: 20:00
PTC Therapeutics Price : 63.46 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 64.81 | 65.40 | 62.80 | 63.46 | 895554.0 |
| Oct 01, 2026 | 64.70 | 65.56 | 63.40 | 64.13 | 1.198M |
| Sep 30, 2026 | 65.16 | 65.50 | 64.14 | 64.78 | 1.043M |
| Sep 29, 2026 | 65.51 | 65.96 | 64.26 | 64.96 | 900436.0 |
| Sep 28, 2026 | 62.35 | 66.26 | 62.30 | 65.95 | 1.914M |
| Sep 25, 2026 | 62.65 | 63.44 | 61.66 | 62.67 | 1.203M |
| Sep 24, 2026 | 62.23 | 62.76 | 61.23 | 62.28 | 1.754M |
| Sep 23, 2026 | 65.80 | 66.15 | 62.24 | 62.34 | 1.101M |
| Sep 22, 2026 | 66.24 | 66.58 | 65.36 | 65.96 | 1.307M |
| Sep 21, 2026 | 65.93 | 66.21 | 64.99 | 65.26 | 1.086M |
| Sep 18, 2026 | 68.00 | 68.00 | 65.18 | 65.37 | 3.865M |
| Sep 17, 2026 | 68.84 | 68.84 | 67.22 | 68.00 | 1.115M |
| Sep 16, 2026 | 65.99 | 67.90 | 65.80 | 67.59 | 1.398M |
| Sep 15, 2026 | 66.51 | 66.54 | 65.06 | 65.65 | 1.034M |
| Sep 14, 2026 | 67.09 | 67.99 | 65.91 | 66.48 | 1.019M |
| Sep 11, 2026 | 67.80 | 68.48 | 65.91 | 66.06 | 792890.0 |
| Sep 10, 2026 | 66.84 | 67.78 | 66.47 | 67.37 | 1.013M |
| Sep 09, 2026 | 68.08 | 68.84 | 67.50 | 67.57 | 1.067M |
| Sep 08, 2026 | 67.81 | 70.08 | 67.48 | 68.81 | 1.118M |
| Sep 04, 2026 | 70.62 | 71.40 | 69.26 | 69.30 | 673540.0 |
| Sep 03, 2026 | 71.76 | 71.97 | 70.55 | 71.40 | 654522.0 |
| Sep 02, 2026 | 71.15 | 72.68 | 69.84 | 71.79 | 902585.0 |
| Sep 01, 2026 | 69.42 | 70.84 | 69.05 | 70.56 | 691015.0 |
| Aug 31, 2026 | 69.98 | 70.42 | 68.76 | 69.54 | 841097.0 |
| Aug 28, 2026 | 71.08 | 71.49 | 69.61 | 70.09 | 692675.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Biogen, Inc. | 219.88 |
| BioMarin Pharmaceutical, Inc. | 57.18 |
| Arcturus Therapeutics Holdings, Inc. | 13.03 |
| ACADIA Pharmaceuticals, Inc. | 19.95 |
| Alnylam Pharmaceuticals, Inc. | 219.72 |
Price Related Metrics
| PS Ratio | 5.384 |
| Earnings Yield | -0.94% |
| Market Cap | 5.288B |
| Operating PE Ratio | 46.53 |